BACKGROUND There is limited data on plaque tissue characterization and phenotype classification using radiofrequency iMAPÔ-IVUS (intravascular ultrasound, Boston Scientific, USA).
METHODS In the iWonder study pts presenting with non-ST-elevation myocardial infarction (STEMI) or STEMI underwent 3-vessel grayscale IVUS and iMAPÔ tissue characterization prior to percutaneous intervention. In total, 385 lesions from 100 pts were divided into culprit (n¼100) and non-culprit (n¼285) lesions defined as >40% of plaque burden longer than 1.5mm in length. Using iMAPÔ vessel and lumen were analyzed for all available frames (approximately every 0.5mm); and volumes were calculated using Simpson's rule. Lesion phenotype was classified in a hierarchical fashion into: (1) TCFA (thin-cap fibroatheromaat least 1 frame with >30 of necrotic core [NC] abutting to the lumen); (2) ThCFA (NC >10%, confluent dense calcium [DC] >10%, well-defined fibrous cap); (3) PIT (pathological intimal thickeningmainly fibrofatty tissue, <10% confluent NC); (4) fibrotic plaque (mainly fibrous tissue, <10% confluent NC, <10% confluent DC) and (5) fibrocalcific plaque (mainly fibrous tissue, >10% confluent DC and <10% confluent NC).
RESULTS Culprit lesions had smaller minimum lumen area with greater plaque burden compared to non-culprit lesions. Volumetric analysis showed that culprit lesions had longer length and larger vessel and plaque volumes compared to non-culprit lesions (Table) . iMAPÔ-IVUS revealed that culprit lesions presented more NC and fibrofatty volume, both at lesion level and at the minimum lumen area (MLA) site (all p<0.001). Also, a TCFA was more prevalent within culprit vs. non-culprit lesions (39.0% vs. 19.0%, p<0.001) anywhere within the lesion as well as at the MLA site (18.0% vs. 9.5%, p¼0.07).
Culprit lesion (n[100)
Non-culprit lesion METHODS Using a graph search algorithm, we developed a computational methodology for automatically outlining the FC border and hence area, overlying an OCT cross-sectional lipid plaque. From a single center OCT database we manually segmented the FC crosssectional (CS) area and surface length at 1mm intervals for the length of 10 lipid plaques comprising 71 slices. FC volume was calculated as the sum of these FC CS areas multiplied by the longitudinal interval between measurements (1mm). The FC surface area was calculated as the sum of FC surface lengths for each CS multiplied by the interval between CS. The mean FC thickness over the entire plaque was defined as the FC volume/ FC surface area. The agreement between manual and automatic segmentation for FC CS area, volume and mean thickness was assessed by Bland-Altman plots and Pearson correlation.
CONCLUSIONS A computer-assisted method of measuring fibrous cap area correlated well with human measurements, and can be used in the future for volumetric assessments of the fibrous cap with a high degree of accuracy. BACKGROUND Culprit lesions in myocardial infarction frequently harbor a lipid burden exceeding a maximum lipid-core burden index in 4-mm (maxLCBI4mm) of 400, as defined by intracoronary near-infrared spectroscopy (NIRS). Whether non-culprit atheroma with a plaque burden !70% (PB70), the intravascular ultrasound (IVUS) characteristic most strongly associated with future lesion-specific events, concurrently harbor a maxLCBI4mm !400 remains unknown. Using hybrid NIRS-IVUS imaging, the present analysis was undertaken to: 1) evaluate the correlation between PB measured by IVUS and lipid burden measured by NIRS in vivo; and 2) determine the prevalence of non-culprit PB70 lesions that have a maxLCBI4mm !400 among non-culprit coronary atheroma.
METHODS Among consecutive patients undergoing NIRS-IVUS imaging as part of a single center registry, non-culprit portions of the target arteries were divided into contiguous 10-mm non-culprit segments. PB in all segments was assessed by quantitative IVUS. Only lesions having a PB !40% were included in the present analysis. NIRSderived lipid burden in all lesions was measured as maxLCBI4mm. Summary statistics were used to describe the relationship between PB and maxLCBI4mm within non-culprit lesions.
RESULTS
In 121 patients, 292 non-culprit lesions (mean PB 56 AE 10%) were identified. A significant but modest positive correlation was found between PB and maxLCBI4mm (R¼0.32, 95% CI 0.22-0.42, p<0.001, Figure) . Although PB70 lesions had a greater maxLCBI4mm than non-PB70 lesions (186 [51, 267] vs. 50 [0, 181], p ¼ 0.02), only 17.1% of PB70 lesions contained a maxLCBI4mm !400. PB70 lesions having a maxLCBI4mm !400 were rare overall, accounting for only 2.1% of all non-culprit plaques.
CONCLUSIONS We found a significant yet modest positive correlation between PB and lipid burden within non-culprit plaques. PB70 lesions harboring a maxLCBI4mm !400 are proportionately rare and accounted for only 2% of all non-culprit plaques. Whether these rare lesions having the IVUS feature most predictive of site-specific future events, coupled with a NIRS lipid burden characteristic of culprit lesions in myocardial infarction, will ultimately associate with future acute coronary events remains unknown. METHODS A total of 14 DESs were examined to compare CAS and histological images. CAS examination was performed based on tissue structure and color intensity classified either white or yellow. Stent coverage was graded as 0, stent struts exposed; grade 1, struts bulging into the lumen, but still transparently visible although covered; grade 2, struts embedded in the neointima, but translucent; grade 3, struts fully embedded and invisible. Each examination was performed at each 3-mm interval of the entire DES.
RESULTS Sixty-one segments were matched to CAS and histological analysis. Of these, 37 were categorized as white and 24 were yellow on CAS. Histological analysis revealed white segments was entirely comprised of smooth muscle cells with an extracellular matrix containing collagens, indicating high neointimal maturity. On the other hand, segments classified as yellow contained fibroatheroma (n¼3), foam cells accumulation (n¼12) or superficial calcium deposition (n¼9) (Figure) . Intimal coverage grade was well correlated with histological neointimal thickness (grade 0 [n ¼ 21] 10AE9 mm, grade 1 [n ¼20] 115AE70 mm, grade 2 [n ¼12] 487 AE243 mm, and grade 3 [n ¼9] 969 AE404 mm; p<0.05).
CONCLUSIONS In-stent yellow intima includes various types of atherosclerotic components, such as fibroatheroma formation, foam cell accumulation and superficial calcium deposition. CAS has the capability to evaluate vascular response of DES accurately.
